Seamus Fernandez

Director, Pharmaceuticals, Major

Seamus Fernandez joined Leerink Swann in 2006 to cover Major Pharmaceuticals. Recently, Mr. Fernandez was ranked #2 by the Financial Times in its “World’s Top Analysts” special report for 2007. In the October 2007 Institutional Investor poll, he was named “Best Up-and-Comer” covering the Pharmaceuticals/ Major sector. Previously, Mr. Fernandez had been a member of the major pharmaceuticals team at Cowen and Company, LLC. Prior to Cowen, Mr. Fernandez was a senior associate at the consulting firm, Putnam Associates, Inc. He began his career as a research associate at the University of Pennsylvania's Department of Neurosurgery where he conducted independent research using gene therapy and transgenic technology. His work was published in the Journal of Cerebral Blood Flow and Metabolism, Experimental Neurology and the Journal of Neurotrama. Mr. Fernandez graduated from Williams College with a B.A. in Chemistry.